327 related articles for article (PubMed ID: 22139383)
61. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
62. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.
Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L
J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597
[TBL] [Abstract][Full Text] [Related]
63. Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy.
Amano S; Li S; Gu C; Gao Y; Koizumi S; Yamamoto S; Terakawa S; Namba H
Int J Oncol; 2009 Dec; 35(6):1265-70. PubMed ID: 19885548
[TBL] [Abstract][Full Text] [Related]
64. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes.
Altanerova U; Jakubechova J; Benejova K; Priscakova P; Pesta M; Pitule P; Topolcan O; Kausitz J; Zduriencikova M; Repiska V; Altaner C
Int J Cancer; 2019 Feb; 144(4):897-908. PubMed ID: 30098225
[TBL] [Abstract][Full Text] [Related]
65. Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines.
Tseng SH; Hwang LH; Lin SM
J Immunother; 1997 Sep; 20(5):334-42. PubMed ID: 9336740
[TBL] [Abstract][Full Text] [Related]
66. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
[TBL] [Abstract][Full Text] [Related]
67. Endothelial cell transplantation for gene therapy in experimental gliomas.
Machein MR; Knoth R; Plate KH
Neurosurgery; 2005 Dec; 57(6):1264-71; discussion 1264-71. PubMed ID: 16331175
[TBL] [Abstract][Full Text] [Related]
68. Anti-proliferative Effect of Engineered Neural Stem Cells Expressing Cytosine Deaminase and Interferon-β against Lymph Node-Derived Metastatic Colorectal Adenocarcinoma in Cellular and Xenograft Mouse Models.
Park GT; Kim SU; Choi KC
Cancer Res Treat; 2017 Jan; 49(1):79-91. PubMed ID: 27188205
[TBL] [Abstract][Full Text] [Related]
69. Mesenchymal stem cells overexpressing PEDF decrease the angiogenesis of gliomas.
Wang Q; Zhang Z; Ding T; Chen Z; Zhang T
Biosci Rep; 2013 Feb; 33(2):e00019. PubMed ID: 22917444
[TBL] [Abstract][Full Text] [Related]
70. Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer.
Kim JH; Yang HJ; Lee SH; Song YS
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791557
[TBL] [Abstract][Full Text] [Related]
71. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.
Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ
Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125
[TBL] [Abstract][Full Text] [Related]
72. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation.
Wu X; Hu J; Zhou L; Mao Y; Yang B; Gao L; Xie R; Xu F; Zhang D; Liu J; Zhu J
J Neurosurg; 2008 Feb; 108(2):320-9. PubMed ID: 18240929
[TBL] [Abstract][Full Text] [Related]
73. Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.
Xu G; Guo Y; Seng Z; Cui G; Qu J
Oncol Rep; 2015 Oct; 34(4):1915-22. PubMed ID: 26252165
[TBL] [Abstract][Full Text] [Related]
74. Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.
Leoh LS; Morizono K; Kershaw KM; Chen IS; Penichet ML; Daniels-Wells TR
J Gene Med; 2014; 16(1-2):11-27. PubMed ID: 24436117
[TBL] [Abstract][Full Text] [Related]
75. [Effect of CXCR4 gene overexpression mediated by lentiviral vector on the biological characteristics of mesenchymal stem cells].
Chen W; Li M; Yan ZL; Chen H; Pan B; Zeng LY; Li ZY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):440-4. PubMed ID: 23688758
[TBL] [Abstract][Full Text] [Related]
76. Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis.
Ho YK; Woo JY; Loke KM; Deng LW; Too HP
J Transl Med; 2024 May; 22(1):463. PubMed ID: 38750559
[TBL] [Abstract][Full Text] [Related]
77. Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancer.
Deng LY; Wang JP; Gui ZF; Shen LZ
World J Gastroenterol; 2011 Jun; 17(24):2958-64. PubMed ID: 21734808
[TBL] [Abstract][Full Text] [Related]
78. Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine.
Kucerova L; Matuskova M; Hlubinova K; Bohovic R; Feketeova L; Janega P; Babal P; Poturnajova M
Cancer Lett; 2011 Dec; 311(1):101-12. PubMed ID: 21824724
[TBL] [Abstract][Full Text] [Related]
79. [Experimental study on the invasion of glioma in vivo].
Zhang X; Li X; Wu J
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):150-3. PubMed ID: 11798866
[TBL] [Abstract][Full Text] [Related]
80. Migration of mesenchymal stem cells to tumor xenograft models and
Kalimuthu S; Zhu L; Oh JM; Gangadaran P; Lee HW; Baek SH; Rajendran RL; Gopal A; Jeong SY; Lee SW; Lee J; Ahn BC
Int J Med Sci; 2018; 15(10):1051-1061. PubMed ID: 30013447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
